Mar 26, 2009
2:1
For every share held, investors received 2. The price per share adjusted from $90.84 to $45.42.
The split itself did not change the total investment value.
Myriad Genetics, Inc. (MYGN) trades on the NASDAQ in the Medical - Diagnostics & Research industry.
Myriad Genetics, Inc. company overviewThe latest split shown was on March 26, 2009. It was a 2-for-1 forward split, so shareholders received 2 shares for every share they held.
This history records 2 forward splits between September 12, 2000 and March 26, 2009.